New Delhi: US President Donald Trump has said he would be surprised if India did not allow the export of Hydroxychloroquine tablets to the United States despite a request made to New Delhi over the subject, and  hinted at a possible retaliation if India does not lift its hold on the export of the anti-malaria drug used in the treatment of coronavirus patients.

Trump speaking from the White House during the Coronavirus taskforce briefing said that India does very well with the US and he sees no reason why India would not lift the hold on the US order of the medicine.

He said, "'didn't hear that that was his (Modi) decision. I know that he stopped it for other countries I spoke to him yesterday, very very good talk, and we'll see whether or not that stays I wouldn't be surprised if he would you know because India's does very well with the United States,"

Trump said that during his recent phone call with Modi, the latter had said he will consider the request of releasing the order to the US.

The US President added, "So I wouldn't be surprised if that was a decision he'd have to tell me that I spoke to him Sunday morning I called him and I said we'd appreciate your allowing our supply to come out. If he doesn't allow it to come out, he doesn't allow it to come out, that would be okay, but of course, there may be retaliation, why wouldn't there be?"

Watch here":


Hydroxychloroquine tablet is used to prevent and treat malaria, lupus and rheumatoid arthritis, among other ailments.

The drug is seen as to offer a viable therapeutic solution to coronavirus that has so far taken the lives of more than 10,000 Americans and infected over 3.6 lakhs, just in a matter of weeks.

Last month, India imposed a ban on export on Hydroxychloroquine, on which Trump is now banking heavily in the treatment of COVID-19 patients.

India has received similar requests from several other countries including its immediate neighbours like Sri Lanka and Nepal. India has said that it is reviewing its export ban order.

Trump said that India and the US have had good trade agreements and hinted at possible retaliation if India decided not to lift the hold. US President Donald Trump on Saturday had said that he has requested Prime Minister Narendra Modi to supply Hydroxychloroquine tablets that can be used to treat COVID-19 patients.

"After call today with Indian Prime Minister Narendra Modi, India is giving serious consideration to releasing the hold it put on a US order for hydroxychloroquine," Trump announced at the White House Coronavirus task force briefing.

(with inputs from agencies)